FELIGEN CRP/R
FELIGEN CRP/R
Authorised
- Rabies virus, strain VP12, Inactivated
- Feline panleucopenia virus, strain LR 72, Live
- Feline rhinotracheitis virus, strain F2, Live
- Feline calicivirus, strain F9, Live
Product identification
Medicine name:
FELIGEN CRP/R
Active substance:
- Rabies virus, strain VP12, Inactivated
- Feline panleucopenia virus, strain LR 72, Live
- Feline rhinotracheitis virus, strain F2, Live
- Feline calicivirus, strain F9, Live
Target species:
-
Cat
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Rabies virus, strain VP12, Inactivated
-
Feline panleucopenia virus, strain LR 72, Live
-
Feline rhinotracheitis virus, strain F2, Live
-
Feline calicivirus, strain F9, Live
Pharmaceutical form:
-
Lyophilisate and suspension for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI06AD04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Available in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- National Veterinary Medicines Agency
Authorisation number:
- FR/V/1404463 0/1988
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
How useful was this page?:
